OTS Member Highlight – Keith T. Gagnon, PhD
As a child, before Keith Gagnon knew anything about science, he told his mom he wanted to be a scientist when he grew up. Now, decades later, Dr. Keith Gagnon is a biochemist and molecular biologist specializing in RNA biology, nucleic acid therapeutics, repeat ...
Interesting Findings on the Impact of Antisense Oligonucleotides on Genome Stability and DNA-Repair Enzyme Activation
Antisense oligonucleotides (ASOs) have emerged as promising drug candidates for the treatment of genetic diseases. Because of their ability to target virtually any disease-related gene product, several ASO drugs have been approved, and many more are in development (1). While they remain among the most ...
